News Releases

Making its debut on the list, UB was ranked No. 8 in the Northeast and No. 48 nationwide in The Princeton Review's 2023 annual ranking.

Allison Brashear, MD, vice president for health sciences and dean of the Jacobs School of Medicine and Biomedical Sciences, has been elected to the AAMC Council of Deans Administrative Board. 

Graduate students have been crafting proposals to transform the land adjacent to the Central Terminal, which covers more than 16 acres, with forward-thinking redevelopment plans aimed at creating a more vibrant, inclusive and sustainable Broadway-Fillmore.

Adedeji, also a scholar at the UB Center for Integrated Global Biomedical Sciences (CIGBS), will receive mentorship and training through CIGBS.

UB-developed scoring system lays groundwork for North America’s first test to predict therapeutic resistance for the rare, but severe disease.

Recently published paper suggests that ‘hypergraphs’ better explain how neuronal networks communicate.

The results of a clinical trial on the drug semaglutide in teens, released in the New England Journal of Medicine, turned out to be better than anything the participants — or even the researchers — expected.

The $15 million National Science Foundation program will foster innovation and accelerate economic development in Western New York, and beyond.

Channavix Therapeutics and Peregrine BioVentures are developing two patent families related to long-lasting, non-opioid, non-addictive pain therapeutics.

Even with varenicline, most people return to smoking within six months of quitting.